简体中文

       We focus on the development of drug candidates to the second phase of clinical studies.  The main research and development direction is anti-fibrotic small molecule drugs, while advancing the development of diabetic, hyperlipidemia and renal anemia drugs.


DrugDiseaseDrug DiscoveryPreclinical ResearchPhase ⅠPhase Ⅱ
Baidu
sogou